COMI, Cristoforo
 Distribuzione geografica
Continente #
EU - Europa 9.682
NA - Nord America 7.426
AS - Asia 5.368
SA - Sud America 935
Continente sconosciuto - Info sul continente non disponibili 322
AF - Africa 192
OC - Oceania 3
Totale 23.928
Nazione #
US - Stati Uniti d'America 7.183
RU - Federazione Russa 2.231
NL - Olanda 1.911
SG - Singapore 1.870
IE - Irlanda 1.492
CN - Cina 1.231
IT - Italia 928
DE - Germania 863
VN - Vietnam 739
HK - Hong Kong 707
BR - Brasile 704
SE - Svezia 622
UA - Ucraina 495
FR - Francia 355
FI - Finlandia 304
IN - India 192
GB - Regno Unito 175
BD - Bangladesh 148
CA - Canada 139
KR - Corea 95
AR - Argentina 89
ID - Indonesia 79
BJ - Benin 78
PL - Polonia 64
JP - Giappone 63
MX - Messico 61
EC - Ecuador 47
ZA - Sudafrica 44
CZ - Repubblica Ceca 43
AT - Austria 38
ES - Italia 37
TR - Turchia 33
IR - Iran 30
IQ - Iraq 29
BE - Belgio 28
CO - Colombia 27
LT - Lituania 23
GR - Grecia 21
PY - Paraguay 21
MA - Marocco 17
SA - Arabia Saudita 17
PH - Filippine 14
PK - Pakistan 14
CL - Cile 13
IL - Israele 13
UZ - Uzbekistan 13
VE - Venezuela 13
EG - Egitto 12
DZ - Algeria 11
PE - Perù 11
AE - Emirati Arabi Uniti 9
EU - Europa 9
RO - Romania 9
AZ - Azerbaigian 8
KE - Kenya 8
NP - Nepal 8
JM - Giamaica 7
KZ - Kazakistan 7
TW - Taiwan 7
UY - Uruguay 7
CH - Svizzera 6
CR - Costa Rica 6
LB - Libano 6
MY - Malesia 6
TN - Tunisia 6
AL - Albania 5
HN - Honduras 5
JO - Giordania 5
KW - Kuwait 5
LV - Lettonia 5
MD - Moldavia 5
SN - Senegal 5
TH - Thailandia 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
PA - Panama 4
AU - Australia 3
BY - Bielorussia 3
DK - Danimarca 3
OM - Oman 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BS - Bahamas 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
LK - Sri Lanka 2
MK - Macedonia 2
NI - Nicaragua 2
NO - Norvegia 2
PR - Porto Rico 2
PT - Portogallo 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
Totale 23.598
Città #
Amsterdam 1.891
Dublin 1.490
San Jose 931
Jacksonville 861
Hong Kong 700
Singapore 651
Ashburn 481
Dearborn 431
Beijing 340
Council Bluffs 335
Moscow 282
Los Angeles 254
Ho Chi Minh City 233
Chandler 213
Lauterbourg 213
Wilmington 199
Lawrence 179
Princeton 179
Hanoi 138
Columbus 135
New York 127
Milan 111
San Mateo 110
Buffalo 107
Ann Arbor 98
Santa Clara 97
Munich 96
Piemonte 89
Dallas 87
Seoul 86
São Paulo 79
Cotonou 78
Novara 74
Andover 72
Helsinki 72
Boardman 68
Orem 68
Turin 63
Rome 55
Dong Ket 52
Warsaw 47
Bremen 45
Chennai 44
Denver 43
Houston 43
Tokyo 43
Toronto 43
Falkenstein 39
Brno 38
Frankfurt am Main 37
Nuremberg 37
Redondo Beach 37
Brooklyn 36
Jakarta 36
Chicago 35
Da Nang 34
Monmouth Junction 34
Woodbridge 34
Guangzhou 33
Hefei 31
Johannesburg 31
Montreal 31
Hangzhou 30
Tianjin 30
Grafing 29
London 29
St Louis 29
Atlanta 28
Phoenix 28
Manchester 27
Poplar 27
Turku 27
Boston 26
Brussels 26
Mumbai 26
Stockholm 26
Torino 26
Strasbourg 25
Haiphong 24
Mexico City 24
Nanjing 24
Seattle 24
Düsseldorf 22
Guayaquil 21
Belo Horizonte 19
Rio de Janeiro 19
Vienna 19
Mülheim 18
Ankara 17
Norwalk 17
Vercelli 17
Charlotte 15
Dhaka 15
Fairfield 15
Hải Dương 15
Kunming 15
Philadelphia 15
Shanghai 15
Alessandria 14
Biên Hòa 14
Totale 13.493
Nome #
Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up 1.918
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 203
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study 177
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report 176
Change over time of COVID-19 hospital presentation in Northern Italy 166
Anti-cytokine autoantibodies in autoimmune diseases 158
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 155
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 152
Circulating extracellular vesicles in subarachnoid hemorrhage patients: characterization and cellular effects 150
Impaired visual inhibition in migraine with aura. 150
Cortical visuomotor interactions in Freezing of Gait: A TMS approach 150
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 149
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 146
Insights into the protective role of immunity in neurodegenerative disease 142
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 141
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 139
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 138
Kappa free light chains could predict early disease course in multiple sclerosis 136
A91V variation of the perforin gene in patients with multiple sclerosis 135
Calcium and glutamate involvement in activation of multiple sclerosis patient lymphocytes 134
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 134
Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs 132
Phenotypic heterogeneity of movement disorders due to intracranial calcifications with or without SLC20A2 mutations 131
Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients 130
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 129
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 129
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 128
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 127
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 127
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 127
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population 127
A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition 126
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 126
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 125
Kappa index for multiple sclerosis diagnosis: an accurate biomarker of intrathecal synthesis 123
An investigation of the role of common and rare variants in a large italian multiplex family of multiple sclerosis patients 123
A case of progressive multifocal leukoencephalopathy after autologous bone marrow transplantation successfully treated with mirtazapine and cidofovir 122
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 121
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 121
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 119
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 119
Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients 119
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 119
ICOS gene haplotypes correlate with multiple sclerosis development and progression 118
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 118
Advances in Neuroimmunology: From Bench to Bedside 117
Short-term videoEEG: Review of a 3-year experience [Short-term videoEEG: Studio retrospettivo di 3 anni di esperienza clinica] 116
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 115
Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence 115
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 114
Complex pattern of convulsive syncope in glossopharyngeal neuralgia: video/EEG report and short review 114
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies 114
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know? 113
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 112
Intrathecal kappa free light chains as markers for multiple sclerosis 112
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 111
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 110
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy 110
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis 107
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 107
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 106
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 106
Osteopontin is increased in the cerebrospinal fluid of patients with early Alzheimer's disease and its levels correlate with cognitive deterioration 106
Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2019) 178(1) (262), (S0092867419306798), (10.1016/j.cell.2019.06.016)) 106
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 105
IV lacosamide: Report of two cases of successful treatment of refractory status epilepticus [Utilizzo di lacosamide ev: Esperienza in due casi di stato di male epilettico refrattario] 105
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 105
Variations of the perforin gene in patients with multiple sclerosis 104
A novel genetic prediction score in myoclonus-dystonia 104
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk 104
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 104
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 102
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 102
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 102
CD4+ T-Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson’s Disease 101
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 101
Serum vitamin d as a marker of impaired information processing speed and early disability in multiple sclerosis patients 101
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 100
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 99
The Need for Biomarkers in the ALS-FTD Spectrum: A Clinical Point of View on the Role of Proteomics 98
A very early onset of juvenile parkinsonism 98
Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis 98
Intensive Rehabilitation Treatment in Early Parkinson's Disease: A Randomized Pilot Study With a 2-Year Follow-up 98
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 98
Coupling motor evoked potentials and brain [18F]FDG-PET in Amyotrophic Lateral Sclerosis: preliminary findings on disease severity 97
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature 97
Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: A retrospective case-control study 97
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 97
Immunity and inflammation in neurodegenerative diseases. 96
Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy 95
The impact of osteopontin gene variations on multiple sclerosis development and progression 95
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 95
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients 95
Lymphocyte Count and Neutrophil-to-Lymphocyte Ratio Are Associated with Mild Cognitive Impairment in Parkinson's Disease: A Single-Center Longitudinal Study 94
CGRP beyond migraine: exploring its serum and CSF levels in multiple sclerosis. 94
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis 94
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 94
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 94
Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2018) 175 6 (1679-1687.e7) PII: S0092-8674(19)30679-8) 94
Totale 13.766
Categoria #
all - tutte 116.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.163 0 36 130 137 57 18 127 22 120 47 176 293
2022/20232.596 204 138 135 27 118 183 85 101 1.439 18 98 50
2023/20241.201 77 52 114 48 202 23 210 70 27 13 108 257
2024/20252.939 65 47 200 96 63 217 288 213 740 207 249 554
2025/202611.859 438 338 675 1.475 981 653 1.521 1.667 2.459 776 606 270
2026/2027677 417 260 0 0 0 0 0 0 0 0 0 0
Totale 23.928